本文關(guān)鍵詞：MDCT對腎透明細(xì)胞癌Fuhrman分級診斷價(jià)值的研究　出處：《中國臨床醫(yī)學(xué)影像雜志》2017年07期 　論文類型：期刊論文

  更多相關(guān)文章： 腎腫瘤 體層攝影術(shù) 螺旋計(jì)算機(jī)

【摘要】：目的:探討腎透明細(xì)胞癌(cc RCC)MDCT影像學(xué)表現(xiàn)與Fuhrman分級之間的關(guān)系。方法:回顧性分析113例經(jīng)手術(shù)病理證實(shí)的cc RCC的MDCT影像資料。兩名放射科醫(yī)生雙盲記錄患者的影像學(xué)特征,包括腫瘤大小、囊性或?qū)嵭浴⑩}化、不均勻性、壞死比、生長方式等,并與Fuhrman分級結(jié)果進(jìn)行統(tǒng)計(jì)學(xué)分析。結(jié)果:14/15例囊性cc RCC為低級別(FuhrmanⅠ~Ⅱ級);在相對較多的實(shí)性cc RCC中,20/27例浸潤型cc RCC為高級別(FuhrmanⅢ~Ⅳ級)。單因素分析顯示腫瘤越大(臨界值為4 cm),Fuhrman分級越高(χ~2=11.441,P0.001);高級別以實(shí)性為主cc RCC中鈣化和壞死比≥0.6較低級別實(shí)性cc RCC多見(χ~2=29.007,P0.001;χ~2=18.454,P=0.030)。多因素分析提示腫瘤大小、浸潤性生長、壞死比≥0.6是實(shí)性為主cc RCC FuhrmanⅢ~Ⅳ級的獨(dú)立預(yù)測因素(OR:0.122,P=0.002;OR:13.234,P=0.002;OR:12.891,P=0.031)。結(jié)論:MDCT對預(yù)測cc RCC Fuhrman分級有較大的應(yīng)用價(jià)值。囊性cc RCC傾向于低級別。以實(shí)性為主cc RCC中,腫瘤越大、浸潤性生長、壞死比(≥0.6)越高,均預(yù)示較高的Fuhrman分級。
[Abstract]:Objective: to study the RCC in renal clear cell carcinoma (RCC). The relationship between MDCT imaging findings and Fuhrman grading. Methods: a retrospective analysis of 113 cases of cc proved by surgery and pathology. MDCT data of RCC. Imaging features of two radiologists were recorded in double blind. These include tumor size, cystic or solid, calcification, heterogeneity, necrosis ratio, growth pattern, etc. Results 15 / 14 / 15 cases of cystic cc RCC were of low grade Fuhrman 鈪，

本文編號：1367129